LATEST

• BUSINESS Organon Dysmenorrhea Drug Mercilon Set for Sept. 1 Launch
  August 18, 2026

• BUSINESS Pfizer, BioNTech Win Japan Nod for XFG-Adapted COVID Vaccines
  August 18, 2026

• BUSINESS 3D Seeks Injunction against Toho’s Poison Pill
  August 18, 2026

• REGULATORY Label Revised for DMD Drug Viltepso Based on PIII Miss
  August 18, 2026

• REGULATORY Trazenta Draws 8 Generic Entrants as Japan Clears New DPP-4 Copies
  August 17, 2026

• ORGANIZATION EFPIA Executive Hails Japan’s Honebuto as “Blueprint” for Europe
  August 17, 2026

• BUSINESS Chiba Downpours Cause No Major Disruption to Drug Operations
  August 17, 2026

• BUSINESS Chugai Files Tecentriq for Colon Cancer Adjuvant Therapy in Japan
  August 17, 2026

• BUSINESS Enflonsia Filed for High-Risk Children in 2nd RSV Season in Japan: MSD
  August 17, 2026

• BUSINESS Healios to File MultiStem in Japan Without Waiting for PIII Results: CEO
  August 17, 2026

• BUSINESS Taiho’s Zipalertinib Hits Primary Goal in 1st Line NSCLC Trial
  August 17, 2026

• BUSINESS Sawai to Drop 46 Generic Products, Takata 30
  August 17, 2026

• BUSINESS Stella Pharma Partners with CBSH on Steboronine in China
  August 17, 2026

• BUSINESS Nippon Shinyaku-Capricor DMD Therapy Dispute Heads to Arbitration
  August 17, 2026

• BUSINESS Roche Diagnostics Files Alzheimer’s Blood Test in Japan
  August 17, 2026

• BUSINESS Astellas Files Veozah in Japan for Menopausal VMS
  August 17, 2026

• BUSINESS Ono, Mediar Team Up on Antibodies for Fibro-Inflammatory Diseases
  August 17, 2026

• BUSINESS Chugai, UCSF Forge Multi-Year Drug Discovery Collab
  August 17, 2026

• BUSINESS Maruishi Gets Japan, Korea Rights to Adneuris Pain Drug
  August 17, 2026

• BUSINESS Wayrilz Offers Potential QOL Benefits for ITP Patients: Expert
  August 17, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »